Correction: Enhanced GAB2 Expression Is Associated With Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-17-0067
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

VISTA Expression Is Associated With a Favorable Prognosis in Patients With High-Grade Serous Ovarian Cancer

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2019English

High Levels of Pretreatment CA125 Are Associated to Improved Survival in High Grade Serous Ovarian Carcinoma

Journal of Ovarian Research
GynecologyOncologyObstetrics
2016English

New in High Grade Serous Ovarian Cancer Treatment

Effective Pharmacotherapy
2019English

Predictors of Long-Term Survival Among High-Grade Serous Ovarian Cancer Patients

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2019English

BRD4 Amplification Facilitates an Oncogenic Gene Expression Program in High-Grade Serous Ovarian Cancer and Confers Sensitivity to BET Inhibitors

PLoS ONE
Multidisciplinary
2018English

Statin Therapy Is Associated With Improved Survival in Patients With Non-Serous-Papillary Epithelial Ovarian Cancer: A Retrospective Cohort Analysis

PLoS ONE
Multidisciplinary
2014English

Identification of Candidate Genes Associated With Tubal Origin of High‑grade Serous Ovarian Cancer

Oncology Letters
Cancer ResearchOncology
2018English

CDK4/6 Inhibition as Maintenance and Combination Therapy for High Grade Serous Ovarian Cancer

Oncotarget
Oncology
2018English

Serous Tubal Intraepithelial Carcinomas Associated With High-Grade Serous Ovarian Carcinomas: A Systematic Review

BJOG: An International Journal of Obstetrics and Gynaecology
GynecologyObstetrics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy